BSH Group | A word from the Chairman

LUPONAX, plastic design and white room production for your biomedical equipment for surgery, transfusion, ophthalmology, dental applications.

For over 20 years the BSH Group has been a robust industrial partner of the plastics sector. As a stakeholder in European economic development through constant innovation, the BSH Group continuously develops new solutions and applications to meet the challenges of the 21st century: Biodegradability, miniaturisation, portability, nanotechnologies, sterilisation, intelligent polymers. In the health sector, LUPONAX helps to improve diagnoses, the quality of care, patient comfort and to fight nosocomial infections. The BSH Group dynamic is focused on being a producer of ideas, an explorer of global solutions, beyond a simple "material forming" role, more of a co-designer at the service of performance. This is where our added value and ability to capture new markets is founded.
But to exist, this approach relies on the unique human capital, our intellectual assets to whom we offer the best possible conditions of motivation and self-realisation, through professional career paths, professional training and the integration of skills in line with the strategy developed. In terms of resources dedicated to our ambitions, LUPONAX will showcase a real flagship in the biomedical plastic sector in 2011, with the construction of a new production site (€3.7 million investment), featuring a 850 m² white room that satisfies ISO 5 and 7.

Philippe Boulette Scola, Président du groupe BSH.

February 15th & 16th, 2012 Pharmapack LUPONAX BIOMEDICAL will be at Pharmapack on February 15th & 16th, 2012, in Paris, Grande Halle de la Villette - Stand n° 363 November 16th to 18th, 2011 Salon MEDICA/COMPAMED Luponax was at MEDICA/COMPAMED - HALL 8B F10. In Dusseldorf, Germany.

> View all news